Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritaka Suga

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|May 4, 2010
[Solid malignancy in patients who received cyclosporine for fibrosing interstitial pneumonia]Kodai Kawamura, Kazuya Ichikado, Hiroyuki Muranaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancerKiyotaka Yoh, Genichiro Ishii, Tomoyuki Yokose, et al.
Cancer|August 28, 2003
Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinomaKiyotaka Yoh, Koichi Goto, Gen-ichiro Ishii, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2002
Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivorsKazuya Ichikado, Moritaka Suga, Nestor L Müller, et al.
Springerplus|August 13, 2016
Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysisKodai Kawamura, Kazuya Ichikado, Makoto Takaki, et al.
Respiratory Research|November 1, 2011
Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatmentArata Azuma, Yoshio Taguchi, Takashi Ogura, et al.
Respiratory Investigation|September 8, 2015
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosisTakashi Ogura, Arata Azuma, Yoshikazu Inoue, et al.
Radiology|November 19, 2005
Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 casesKazuya Ichikado, Moritaka Suga, Hiroyuki Muranaka, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2005
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosisArata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi, et al.
Respiratory Investigation|November 2, 2015
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in JapanYasuhiro Kondoh, Hiroyuki Taniguchi, Masahito Ebina, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|May 4, 2010
[Solid malignancy in patients who received cyclosporine for fibrosing interstitial pneumonia]Kodai Kawamura, Kazuya Ichikado, Hiroyuki Muranaka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancerKiyotaka Yoh, Genichiro Ishii, Tomoyuki Yokose, et al.
Cancer|August 28, 2003
Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinomaKiyotaka Yoh, Koichi Goto, Gen-ichiro Ishii, et al.
American Journal of Respiratory and Critical Care Medicine|June 5, 2002
Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivorsKazuya Ichikado, Moritaka Suga, Nestor L Müller, et al.
Springerplus|August 13, 2016
Efficacy of azithromycin in sepsis-associated acute respiratory distress syndrome: a retrospective study and propensity score analysisKodai Kawamura, Kazuya Ichikado, Makoto Takaki, et al.
Respiratory Research|November 1, 2011
Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatmentArata Azuma, Yoshio Taguchi, Takashi Ogura, et al.
Respiratory Investigation|September 8, 2015
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosisTakashi Ogura, Arata Azuma, Yoshikazu Inoue, et al.
Radiology|November 19, 2005
Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 casesKazuya Ichikado, Moritaka Suga, Hiroyuki Muranaka, et al.
American Journal of Respiratory and Critical Care Medicine|January 25, 2005
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosisArata Azuma, Toshihiro Nukiwa, Eiyasu Tsuboi, et al.
Respiratory Investigation|November 2, 2015
Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in JapanYasuhiro Kondoh, Hiroyuki Taniguchi, Masahito Ebina, et al.
Pageof 6